AARD News

Aardvark Therapeutics, Inc. (AARD) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 13, 2026 Deadline

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD

AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class Action

Faruqi & Faruqi, LLP Urges Aardvark Therapeutics (NASDAQ: AARD) Investors to Seek Counsel Before October 13, 2026 Lead Plaintiff Deadline in the Securities Class Action

AARD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

DEADLINE ALERT for HDB, SMPL, and AARD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

AARD Shareholder Alert: October 13, 2026 Lead Plaintiff Deadline in Aardvark Therapeutics, Inc. Securities Class Action - Contact SueWallSt

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD

Recover Investment Losses: Class Action Initiated Against Aardvark Therapeutics, Inc. (AARD)

Class Action Alert: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. (AARD) Investors of October 13, 2026 Deadline